A new Fitbit study is looking at how wearables, including the Pixel Watch, can “help people better understand and improve their metabolic health to stay healthier.”
For example, the latter includes premature aging and cardiovascular system stress, while serving as a leading cause of hypertension, high cholesterol, Type 2 Diabetes, and other conditions.
Diet, exercise, sleep, and other lifestyle factors, which trackers and smartwatches you already wear on a daily basis already track, impact metabolism.
This WEAR-ME study is done in partnership with Quest Diagnostics. Fitbit wants to “find ways for people to better understand their metabolic health and implement lifestyle changes to build a healthier life.” Scroll to the bottom of the Google Health Studies app to learn more and join.
Related: Google launches Sleep Quality Study to improve Fitbit
More specifically, Google aims to see whether AI and ML algorithms can “detect early signs of metabolic deterioration” after looking at heart rate, HRV (heart rate variability), sleep cycles, and stress levels.
Besides sharing your biometric signals from a Fitbit tracker/smartwatch or Pixel Watch, this metabolic health study will also look at biomarker data in blood samples. Those that participate might be eligible for a “free blood draw facilitated by Quest that includes a comprehensive metabolic panel and measuring cholesterol, triglycerides and insulin levels.”
To sign-up for the WEAR-ME study, you have to be a:
Pixel Watch or Fitbit user
Have an Android phone with the Google Health Studies app installed
Between the ages of 21 and 80
Based in the United States (except Hawaii, Alaska, and Arizona)
Willing to “go to one of thousands of Quest Diagnostics Patient Service Centers for a blood draw”
Complete four questionnaires, share Fitbit data from three months prior to joining the study, and for the duration — “study participants will have a period of 70 days to complete the study”
Add 9to5Google to your Google News feed.
FTC: We use income earning auto affiliate links. More.